Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

11th PCNE Working Conference 2019, Egmond aan Zee, the Netherlands

Targeting patients and tailoring Pharmaceutical Care: How to be outstanding

6-9 February 2019


Targeting patients and tailoring Pharmaceutical Care: How to be outstanding

6-9 February 2019




Welcome to Egmond aan Zee in the Netherlands!  Vuurtoren jpg

Pharmaceutical care is the pharmacist’s contribution to the health of individual patients. In addition to compounding and dispensing medicines, providing comprehensive pharmaceutical care has become the main activity of the profession. Pharmaceutical care is the care of the pharmacist, that aims to support the patient in his optimal medication use, in order to improve individual health outcomes. This implies that the medication provided must fit each patient in the best possible way.

However, individual needs vary and not all patients need the most extensive form of pharmaceutical care. Consequently, simple and feasible methods are needed to target those patients that will benefit most from tailored pharmaceutical care. Both processes, targeting as well as tailoring care need an efficient organisation.

Our international working conference will focus on a number of practical questions related to this topic:

-          Which tools have to be developed to assess the pharmaceutical care needs of individual patients?

-          How can existing tools be optimized to target patients and to tailor pharmaceutical care for the individual patient?

-          How should such tools be implemented in daily hospital and community pharmacy practice?

Apart from the lectures, five workshops will be held. Each workshops will last approximately 12 hours. This gives participants the possibility to be really creative, and reach for results that can be used in their own research. One workshop is more educational, aimed at starting researchers and dealing with methodologies for research and aspects around obtaining funding. Participants must choose one workshop for the whole conference!

Accreditation for Dutch hospital pharmacists and community pharmacists has been obtained.

Please do note that the conference fee (Early Bird 675 Euro) includes accomodation and meals.

Egmond aan Zee is at the sea. Each morning, an early wake-up walk will be organised along the beach. A surprise event will be organised on Thursday.

Amsterdam 1


Meet old friends, and make new friends! Although PCNE is growing, many participants of the working conferences know each other, and the social aspect will certainly not be neglected.  On Friday, an excursion to Amsterdam, with a real Indonesian-Dutch ‘rijsttafel’-dinner, is the social highlight of the conference.

We look forward to seeing you in Egmond aan Zee.


Martina Teichert (PCNE Chairman) and Jacqueline Hugtenburg (PCNE Secretary) , and the other members of the organising committee


The preliminary program of the conference can be downloaded here as printable PDF


The organisation of the conference is supported by KNMP, the Royal Dutch Association for Pharmacy, SpringerNature, Pluriplus and ZonMw.


PCNE logo 2017 KNMP logo 100 kleur rgb  Springer    Pluriplus logo 

As usual for a PCNE working conference, there are four lectures 

  • How to use pharmacogenetics to select patients for pharmaceutical care. Prof. Henk Jan Guchelaar, Leiden, The Netherlands

Pharmacogenomics is the study of genetic variability affecting an individual’s response to a drug. Its use allows personalized medicine and reduction in ‘trial and error’ prescribing, leading to more efficacious, safer and cost effective drug therapy. Technical developments have moved the field from reactive genotyping to a pre-emptive panel approach: in this latter approach patients are tested for a panel of genetic variants even before drug prescribing has taken place. When these data are included in a patient’s electronic medical record, this allows pharmacists and physicians to use this information at time of medication surveillance and drug prescribing.

Due to its highly developed pharmacy ICT infrastructure, The Netherlands healthcare system and especially pharmacists are at the forefront of implementing pharmacogenomics into routine clinical practice. Several pharmacist initiated pharmacogenomics implementation projects both in primary and secondary care have successfully been completed. Recently, an EU Horizon2020 project Ubiquitous Pharmacogenomics (U-PGx) was funded and investigates the approach of pre-emptive panel testing using a randomized clinical trial design in 7 EU countries and including a total of 8,100 patients. Feasibility, health outcome, especially the reduction of adverse drug events, and cost-effectiveness will be studied. The U-PGx consortium ultimately aims to formulate European strategies for further improving implementation of pharmacogenomics.


  • Selecting the right patient for medication reviews. Prof. Petra Denig, Groningen, the Netherlands

Various types of medication reviews are recognized, ranging from simple reviews based on the medication history available in the pharmacy to advanced, multidisciplinary reviews based on medication history, patient information and clinical information. For providing efficient and optimal pharmaceutical care, it is important to select the right patient for the right type of medication review. To guide this decision, we can focus on patient characteristics (e.g. age, adherence, beliefs), clinical characteristics (e.g. kidney function, fall risk, comorbidity), medication characteristics (e.g. high risk medication, inappropriate medication) or a combination of such characteristics. Basic principles regarding what we consider as optimal medication treatment can assist us in this process. In addition, we can make use of prediction studies to develop algorithms for distinguishing between patients with low or high complexity in need of simple or more advanced medication reviews. General principles and results from a recent study testing such an algorithm will be presented.


  • Goal Attainment Scales to facilitate person-centred pharmacy consultations. Dr. Katrina Clarkson and Dr. Nina Barnett, London, UK

Goal attainment scaling is a standardised measure of achievement of goals and is used to compare outcomes for different populations.  In the rehabilitation setting, this measure helps patients to identify their goals and measure their success over time in achieving their goals. This presentation will focus on the use of Goal Attainment Scaling (GAS), using clinical examples from the rehabilitation setting, to suggest how GAS can be used in pharmacy practice.  The use of a coaching approach to consultations, which includes goal setting, provides an opportunity to integrate GAS methodology into medicines-related consultations. Using examples from pharmacy practice, the presentation will outline methods of measuring goal attainment as part of person-centred pharmacy conversations to support medicines optimisation.​


  •  Social media and pharmaceutical care. Dr. Mahendra Patel, Huddersfield, UK



PCNE liggend 500x300px


Please note: Participants can select only one workshop for the whole conference (and a spare one). Changing workshop during the conference is not appreciated.

Workshop 1:  Using pharmacogenetics to select patients for pharmaceutical care.
Facilitators: Ms. Cathelijne van der Wouden MSc, Dr. Martina Teichert

Pharmacogenetics (PGx) is the field in which an individual’s genetic makeup is used to guide pharmacotherapy, thereby personalizing medicine. Several randomized controlled trials have concluded that for some genetic variations genotyping a patient before initiation of a specific drugs can help to optimize patient treatment outcomes. To this guidelines have been developed guiding clinicians to select drug and dose based upon an individual’s genotype. However, implementation of these recommendations into clinical practice remains a challenge. The critical question still is: ‘Whom do we have to genotype when?’

In this workshop we will discuss the concept of PGx, get acquainted with guidelines for optimizing pharmacotherapy based on genotypes of pharmacogenes, dive into evidence from literature on specific gene – drug interactions, and discuss critical voices on the clinical utility and feasibility of PGx. Finally participants will develop a generic guideline on the implementation of PGx and design their own pharmacogenetics implementation approach.

An extended description of Workshop 1 can be found here


Workshop 2: How to find the right patients for specific pharmacy services
Facilitators: Dr. Ellen Koster (Utrecht University, the Netherlands), Dr. Martin C Henman (Trinity College Dublin, Ireland), Prof. dr. Petra Denig (University of Groningen, the Netherlands)

Every patient is different. Patients differ in age, gender, medical history, socio-economic status, ethnic background and related characteristics, such as, frailty and health literacy skills, which can lead to differences in health outcomes, (perceived) illness and use of health care services. To provide good pharmaceutical care, it is important to take the clinical as well as the personal needs of the patients into account. In this workshop we will discuss which patients need specific pharmacy services and how to identify these patients in pharmacy practice to provide tailored pharmaceutical care. Examples of such tailored care will be addressed in relation to identified target groups.

An extended description of Workshop 2 can be found here


Workshop 3: How to use social media to tailor pharmaceutical care
Facilitators: Dr. Mahendra Patel, Mr. Babir Malik, Dr. Jacqueline Hugtenburg, assisted by Dr. Foppe van Mil

Social media are a newer means of communication between people, but are hardly used in health care yet. The techniques seem quite suitable for exchange of personal notes, short movies and doing pharmaceutical care counselling activities. Some social media platforms seem more suitable for such exchanges than others. What privacy issues are involved? Which media are especially suitable for face-to-face communication? What precautions should be taken, and how can we define some guidelines and protocols?


Workshop 4 :  How to upgrade quality of my pharmaceutical care research design (educational workshop).
Facilitators: Prof. Mitja Kos, Dr. Nejc Horvat

 The aim of this workshop is to get a qualified and peer-reviewed feedback on your own pharmaceutical care research project in order to advance the quality of research design. Participants will present their research designs of their current and/or past research projects. In-depth discussion will be stimulated in order to get a relevant feedback from the group as well as workshop-leaders. Experiences from the past research involvements will be used to understand the advantages and disadvantages as well as the feasibility of possible methodological approaches. Based on the qualified and peer-reviewed feedback the participants will aim to advance their research project designs.

An extended description of Workshop 4 can be found here


Workshop 5: Building concrete tools for pharmaceutical care research: development of a core outcome set and a goal attainment scale.
Facilitators: Prof. Veerle Foulon, Dr. Isabell Arnet

This workshop will build on the results of previous PCNE workshops on Core Outcome Sets (in 2017 and 2018). During these former workshops, a draft protocol has been developed to define a Core Outcome Set for interventions to optimize the medication use of people discharged from hospital. The aim of the present workshop is to further develop the protocol and make clear decisions on methodology and involvement of researchers. The workshop is NOT reserved for former participants but open to all persons interested in COS and GAS at all stages of their career. 

During the workshop will briefly recap basics on COS and the work performed in the previous years, and open the discussion on how the outcomes, defined in the Core Outcome Set, could be measured. As an add-on to existing instruments (e.g. for the detection of hospital-related (re)admissions), the option of a Goal Attainment Scale as a person-centred alternative, will be investigated.

In a 2-hour sub-workshop, Katrina Clarkson and Nina Barnett (UK) will demonstrate how GAS can be used as part of medicines-related conversations, including medication review, as an outcome measure. This will include revision of SMART goals (specific, measurable, achievable, realistic and time-constrained) in relation to GAS. Demonstration of a health coaching conversation will be provided together with an opportunity for participants to practise this technique. This will be followed by case scenarios which will include examples of using GAS goals in both rehabilitation and medicines scenarios, and a discussion of the difference between clinician identified and patient identified goals. Participants will be asked to work through the translation of a patient-stated goal into a SMART clinical goal within the GAS framework, describing the different levels of possible achievement. Each group will provide short feedback, facilitated by the workshop leaders.



Click here to download a full program booklet

Click here for a downloadable program overview


Wednesday 6 February 2019


Registration (lunch available) and committee meetings


Welcome & announcements


Plenary Lecture: How to use pharmacogenetics to select patients for pharmaceutical care. Prof. Henk Jan Guchelaar, Leiden, The Netherlands


Workshops, incl. tea break


Oral communications




Thursday 7 February 2019


Plenary lecture: Selecting the right patient for medication reviews. Prof. Petra Denig, Groningen, the Netherlands


Workshops continued, including coffee break


PCNE Soapbox Part 1 (PCNE Members only) / Poster viewing


Lunch & poster viewing


Plenary lecture: Goal Attainment scales and core outcomes in pharmaceutical care. Dr. Katrina Clarkson and Dr. Nina Barnett, London, UK


Workshops continued, incl. tea break


Poster discussion & drinks






Friday 8 February 2019


Plenary lecture: Social media and pharmaceutical care. Dr. Mahendra Patel, Huddersfield, UK


Workshops continued, incl. coffee break


PCNE Soapbox Part 2 (PCNE Members only) /  Poster viewing


Lunch & poster viewing


Workshops continued, incl tea break


Group photo


PCNE Social event (separate registration)


Saturday 9 February 2019


Workshops continued, incl. coffee


Reporting, Awards and conference closing


Walking Lunch and Good byes


PCNE General Assembly (PCNE Members only)

The submitted abstracts relate mostly to the conference themes: patient targeting and tailoring of pharmaceutical care. A few abstracts relate to other pharmaceutical care related topics such as mediciation review, drug-related problems or seamless care.

The abstract submission started 14 October 2018 and ended 11 November 2018 at 24.00h sharp. Accepted abstracts shall be presented as posters or short oral communications, depending on the judgement and opinion of the scientific committee. A list of all accepted abstracts can be found below.

The organising committee wishes to thank all members who contributed to the review of the abstracts.

Awards are available for the best poster and the best oral communication.

Scientific committee:

Dr. Ellen Koster, the Netherlands
Dr. Foppe van Mil, the Netherlands
Dr. Isabelle Arnet, Switzerland
Dr. Jacqueline Hugtenburg, the Netherlands
Dr. Kirsten Viktil, Norway
Dr. Martina Teichert, Chair, the Netherlands
Prof. Mitja Kos, Slovenia
Dr. Nejc Horvat, Slovenia
Prof. Veerle Foulon, Belgium


List of accepted abstracts (click on the title to see the abstract)

ID Title Scope Organization
269 Challenges of administering oral medications to older people with swallowing difficulties: A hard pill to swallow? Drug-related problems School of Clinical Sciences, Queensland University of Technology (QUT)
273 Patients’ and providers’ perspective on medication relatedness and potential preventability of hospital readmissions within 30 days of discharge Drug-related problems OLVG, Department of Clinical Pharmacy, Amsterdam, The Netherlands
274 Which part of unplanned hospital readmissions within 30 days after discharge is medication related? Drug-related problems Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, The Netherlands
278 Drug-related problems among patients with arterial hypertension and/or diabetes type 2 in Pharmaceutical Care in Arterial Hypertension and Diabetes (PCAHD) national programme Drug-related problems Department of Social Pharmacy, Jagiellonian University Medical College
292 Adverse drug reactions on sexual functioning: a systemic overview Drug-related problems Leiden University Medical Center, Department of Clinical Pharmacy & Toxicology, Leiden, The Netherlands
295 Variables associated with medication non-adherence in patients with COPD in Amman Drug-related problems Jordan University of Science and Technology
301 Pharmacogenetic information in drug labels: large heterogeneity Drug-related problems Pharmaceutical Care Research Group, University of Basel, Switzerland
320 Prevention of drug related problems: the added value of a clinical decision support system for daily practice. Drug-related problems Royal Society of Pharmacists of East Flanders (KOVAG)
327 INAPPROPRIATE OTC-MEDICINES FOR OLDER PEOPLE IN SLOVAKIA Drug-related problems Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cormenius University, Bratislava, Slovakia
334 Development of an electronic tool for reducing medication regimen complexity that considers the patients’ preferences. Drug-related problems Department of Clinical Pharmacology & Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany; Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany
339 Identification of drug-related problems in the Polish elderly with hypertension, recommendations for patients – a preliminary study Drug-related problems Medical University of Warsaw
349 The effect of a Geriatric Stewardship on drug-related problems after discharge Drug-related problems OLVG, Hospital pharmacy, Amsterdam, the Netherlands
276 m-Health related information seeking behaviour for chronic conditions and medications in patients, health professionals and health science students E-health and pharmacy University of Prishtina, Faculty of Medicine, Department of Pharmacy Practice and Pharmaceutical Care
291 Pharmacogenetics in Bot PLUS: boosting individualized pharmaceutical care. E-health and pharmacy Consejo General de Colegios Oficiales de Farmacéuticos, Spain.
296 Exploring e-health literacy and medication adherence in patients with diabetes E-health and pharmacy University of Prishtina -The Faculty of Medicine-Departament of Pharmacy
307 SELF-management maintenance Inhalation therapy with EHealth (SELFIE); a study on eHealth use in patient care and research E-health and pharmacy Radboud university medical centre, Radboud Institute for Health Sciences, Department of IQ healthcare,
331 Domestic internet purchasing and sources of cannabis for medicinal use within different countries: a systematic review E-health and pharmacy Medicines Use Research Group, Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Surgery, University of Malta.
343 Customized adherence estimation for polypharmacy: Validation of new algorithms to combine dispensing, prescription, and hospitalization data E-health and pharmacy Université Claude Bernard Lyon 1
268 Implementation of shared decision making in mental health through the use of a validated questionnaire: My Medicines and Me (M3Q) General pharmaceutical care The University of Western Australia
270 LactaMap: An online lactation care support system for healthcare professionals General pharmaceutical care The University of Western Australia
275 Services and costs of pharmaceutical care in Ethiopia General pharmaceutical care Deakin University
288 A logic model for pharmaceutical care General pharmaceutical care National Institute for Public Health and the Environment (RIVM)
297 Comprehensibility, clarity, and usability of over-the-counter medication labels: Consumers’ perspectives and needs in Taiwan General pharmaceutical care Chen-Fang Pharmacy, Yilan County, Taiwan
299 Roundtables between homecare and community pharmacy about medication to increase patient safety General pharmaceutical care Pharmakon
300 Design and evaluation of a fine-tuned counseling approach by community pharmacists tailored to patients’ needs of over-the-counter medications General pharmaceutical care Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University; University of Wisconsin-Madison, Wisconsin, USA
305 Study of pharmacists' attitude and willingness to provide additional services in Bulgaria General pharmaceutical care Bulgarian Pharmaceutical Union
306 Cooperation between municipalities and pharmacies on local health promotion General pharmaceutical care Pharmakon
311 Effectiveness of a patient-tailored, pharmacist-led intervention program to enhance adherence to antihypertensive medication: the CATI Study General pharmaceutical care Department of Clinical Pharmacology and Pharmacy and the Amsterdam
313 Patients’ needs and wishes regarding pharmaceutical care provided by the pharmacist for women treated with adjuvant endocrine therapy for breast cancer. General pharmaceutical care Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC-VUmc
329 Analysis of pharmaceutical care services in Serbian community pharmacies – comparative study General pharmaceutical care University of Belgrade – Faculty of Pharmacy
337 Nutritional intervention in community pharmacies through the use of a decision support system (DSS): a novel approach to Pharmaceutical care. General pharmaceutical care Nutrition and Dietetic Department, Harokopio University, Athens, Greece
341 Treatment of uncomplicated urinary tract infection : a retrospective cohort study in women of 18 years and older using pharmacy dispensing data General pharmaceutical care KNMP (Royal Dutch Pharmacists Association)
344 PREVALENCE OF FRAILTY AND SPATIOTEMPORAL DISORIENTATION IN COMMUNITY PHARMACY General pharmaceutical care Centre Hospitalier de Chaumont-en-Vexin
345 Cardiovascular Risk Assessment Campaigns in Community Pharmacies: contributing to CVD prevention General pharmaceutical care Farmácia Nuno Álvares
346 Adult anti-pneumococcal primo-vaccination: what can the pharmacist do to achieve better implementation of the guidelines? General pharmaceutical care KOVAG - Royal Society of Pharmacists of East-Flanders
277 Patient Perceptions of Medication Management Post-discharge: Do Home Medicines Reviews (HMR) make a difference? Medication review Department of Pharmacy and Complex Needs Coordination Team, Sir Charles Gairdner Hospital, Nedlands WA, 6009, Australia
303 Internal and external evaluation of an interdisciplinary medication management service in Germany Medication review ABDA - Federal Union of German Associations of Pharmacists
318 Effective and rationale medicines use review in Slovenia - evidence based policy Medication review University of Ljubljana, Faculty of pharmacy
323 The impact of medication review by Belgian community pharmacists on adherence, a pilot study Medication review APB
324 Optimizing antipsychotic medicines use among the elderly: preliminary results of the potential use of web-based tools for cardiovascular safety Medication review Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Caparica, Portugal
333 Which patients should receive a medication review? Variables associated with the identification of drug-related problems during medication reviews Medication review KU Leuven
335 The use of Goal Attainment Scaling during clinical medication review in older persons with polypharmacy Medication review SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands
336 Effects of a clinical medication review focused on personal goals, quality of life and complaints in older persons with polypharmacy; a randomised controlled trial (DREAMeR-study) Medication review SIR Institute for Pharmacy Practice and Policy
347 The Effect of Clinical Medication Review on Morbidity, Hospital Admission/Readmission or Mortality Caused by Drug-Related Problems: A Systematic Review Medication review Amsterdam UMC, Vrije Universiteit Amsterdam, department of Clinical Pharmacology and Pharmacy
348 Patients with pharmacotherapy changes as a potential target group for medication use review: a study plan Medication review University of Ljubljana, Faculty of pharmacy
298 Patients' perceptions and preferences in relation to 3D printed medicines Others [Exceptional use] University of Copenhagen
310 Antipsychotic drug consumption in Portugal: a nationwide trend from 2008 to 2017 Others [Exceptional use] Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Caparica, Portugal
271 Developing PHarmacie-4 - A simple risk tool to identify patients at risk of medication-related problems post-discharge. Outcomes research and COS The University of Western Australia
272 Informing how to translate the Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) into practice Outcomes research and COS The University of Western Australia
293 ANTICHOLINERGIC BURDEN VERSUS ANTICHOLINERGIC EFFECTS IN INSTITUTIONALIZED ELDERLY Outcomes research and COS Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra / Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal -
316 Influence of patients' beliefs about the disease and medication in adherence to antihypertensive therapy Outcomes research and COS Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra / Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal -
317 Use of health information technologies to obtain the best possible medication history - an experience in a psychiatry ward Outcomes research and COS CAPES Fellow 11915/13-7 (CAPES Foundation, Ministry of Education of Brazil), Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, Coimbra University, Portugal
290 A pilot questionnaire-based survey about Bulgarian pharmacists’ opinion for implementation of pharmaceutical care for patients with rare diseases PhC Implementation research Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Medical University-Sofia
302 Experience and possible applications for a creatinine Point of Care Test (POCT) in community pharmacy practice. PhC Implementation research Utrecht University
304 Development of a set of quality indicators for home pharmaceutical care in Japan PhC Implementation research The University of Sydney
325 The role of the pharmacists in vulnerability and frailty in an integrated care environment: development of an education program. PhC Implementation research KOVAG
294 Patients' perspectives on medication management at hospital discharge - A qualitative study Seamless care Pharmaceutical Care Research Group, University of Basel
309 Standardizing and improving medication reconciliation implementation strategies by enhancing the consistency in the classification of medication discrepancies Seamless care The University of Sydney School of Pharmacy
321 Effect of clinical pharmacist’s interventions during a patient’s path through the hospital on the pattern of drug-related problems at discharge – a study design Seamless care Pharmaceutical Care Research Group, University of Basel, Switzerland
312 Medication appropriateness for elderly nursing home residents with a limited remaining life expectancy: Adjusting the START/STOPP criteria by means of a Delphi consensus study Standards and guidelines for PhC Department of General Practice and Elderly Care Medicine, Amsterdam UMC-VUmc
314 STOPP/START Criteria and patients’ clinical information requirements – a study about its applicability Standards and guidelines for PhC Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal

Zuiderduin entree 2017The conference will be held in a seaside hotel, Hotel Zuiderduin in Egmond aan Zee, the Netherlands. Egmond is approx. 50km from Amsterdam-Schiphol, and can be reached by train and bus.



Possibly, shuttlebusses will be organised, depending on the arrival times of the participants. If no shuttle is available, then the easiest way to Egmond aan Zee is with public transport: first the train from Schiphol Airport to Alkmaar and then the bus to Egmond aan Zee.

Train: Schiphol-Alkmaar

Single train tickets can be bought online on the website of the NS (Dutch railways): (English website). The ticket can be printed or or downloaded to the Reisplanner Xtra app on a smartphone. Tickets can also be bought at Amsterdam Airport Schiphol using the vending machines ( or at the counter. A supplement of €1 is charged when a ticket is bought at the counter or a vending machine. You can pay with debit or credit cards. But please note that only credit cards with a pin code are accepted, and a € 0.50 supplement is charged for credit card transactions.

then Bus: Alkmaar - Egmond aan Zee

Upon arrival in Alkmaar, please find the bus to Egmond: Line number 165. A bus will leave every 30 minutes during the day, and every hour after 19.00h . You can pay in the bus with a debit or creditcard, or use the public transportation card.

Public transportation card (OV-Chipcard)

If you plan to travel with public transport, you can consider buying an OV-Chipcard (€7.50). You can load the single tickets on the card using the vending machines and the supplement of €1 won't be charged. For more informatie, see:


Early arrival

Participants who arrive one night before the conference will have a reduced fee for room + breakfast of 45 Euro/night for that night.

Zuiderduin congresbalie.JPG


Conference venue

The conference will be held at

Hotel Zuiderduin,
Zeeweg 52,
1931 VL Egmond aan Zee
The Netherlands

Phone: +31 72 750 2000




February in the Netherlands can be cold, stormy and wet.
Bring a nice warm pullover and an umbrella (or even better, a raincoat) and sturdy shoes if you want to be outside.



All conference participants can use the hotel Wifi for free.


Office and slide preview

The conference organisation has its own office, where a laptop & printer and a photocopy machine will be installed. Slides can be previewed in the office.



For all information, please contact the PCNE office at

CVs of speakers and facilitators


Professor Nina L Barnett, PhD FFRPS FRPharmS IPresc JP, United Kingdom

Consultant Pharmacist, Care of Older People, Pharmacy, Northwick Park Hospital. 
London North West Healthcare NHS Trust &  NHS Specialist Pharmacy Service 
Honorary Reader, School of Pharmacy, University College London
Visiting Professor Institute of Pharmaceutical Science Kings College London

Nina Barnett is a Consultant Pharmacist with a proven track record in both strategic an operational development relating to clinical pharmacy and clinical leadership in the area of older people. Nina has developed and delivered MSc level courses to health care professionals including care of older people and prescribing pharmacists at The School of Pharmacy University College London and Kings College London, where she is currently a Visiting Professor. She has also designed and delivered health coaching training to consultants, GPs nurses, pharmacists and other health professionals, nationally and internationally. Nina has pioneered the use of coaching in pharmacy to optimising patient adherence and is a national leader in use of health coaching for medicines-related patient care.  She has devised and published work on a person-centred approach to medication review to promote medicines optimisation, management of polypharmacy and safe, effective deprescribing.

Her current work includes developing, implementing and validating the award winning integrated medicines support service (HSJ awards 2015) focussing on reducing risk of preventable medicines-related readmission for older people in both hospital and primary care. Working with Kings College London she is developing methods to integrate supporting medicines adherence, polypharmacy management and deprescribing into undergraduate and postgraduate teaching, using a person-centred approach. She has recently completed a doctorate on the subject of “Developing a person-centred approach to pharmacy practice”.

 Nina Barnett.jpg

Katrina Clarkson, MSc BSc (Hons) MRCSLT, United Kingdom

Principal Speech and Language Therapist, Regional Hyper-acute Rehabilitation Unit
Northwick Park Hospital, Watford Road, Harrow, HA1 3UJ
Visiting lecturer at Kings College, University of London
Functional Independence Measure and Functional Assessment Measure (FIM+FAM) Trainer

Katrina qualified as a Speech and Language Therapist from University College London (UCL) in 1999.  She went on to complete her Masters in Neuroscience, Language and Communication, also at UCL in 2014.  Since qualifying she has worked at a number of major hospitals across London within the field of adult acquired neurology.  She specialises in acquired brain injury including stroke and traumatic brain injury.   Katrina’s clinical experience has been split between acute services, and for the last ten years, working in post-acute and hyper-acute, in-patient, neuro rehabilitation.  She has also spent time working in Sri Lanka, and supporting the SLT degree programme in Colombo.

Katrina is currently working on the Regional Hyper-acute Rehabilitation Unit at Northwick Park Hospital, part of the London North West University Hospitals Trust. Multidisciplinary team working is integral to her work, together with the use of outcome measures such as Goal Attainment Scaling (GAS) and FIM+FAM on a daily basis.  Additionally, her areas of professional interest are around outcome measures, service satisfaction reporting for people with aphasia, tracheostomy, and prolonged disorders of consciousness.  Katrina is a visiting lecturer at Kings College London, teaching on their stroke course for nurses, as well as being a FIM+FAM lecturer and workshop facilitator both nationally and internationally. She also provides supervision and support to Speech and Language Therapists both within the department and outside of the Trust.

Katrina Clarkson.JPG

Professor Dr. Petra Denig, PhD, the Netherlands

Prof dr Petra Denig is professor of Drug Utilization Quality at the University of Groningen in The Netherlands. She is head of research of the Clinical Pharmacy and Pharmacology Department at the University Medical Center Groningen. She is also program leader of the Real world studies in PharmacoEpidemiology, -Genetics, -Economics, & -Therapy (PEGET) program. Major research aims are developing innovative strategies and insights that contribute to optimal and personalized use of medication in practice. The focus is on chronic and complex diseases, particularly cardiovascular diseases and diabetes.

Petra Denig has published more than 100 peer-reviewed papers about medication use and prescribing, medication adherence, educational interventions/tools. Together with her co-workers, she has developed and evaluated educational modules, decision support tools and feedback material for practitioners and patients to optimize medication use and medication treatment outcomes in practice-based settings. This includes the development of patient selection criteria for interventions or monitoring. 

Petra Denig is member of several expert groups, including the Working Group Prescription Feedback of the Dutch Institute for Rational Use of Medicine and the Working Group Deprescribing for the national Multidisciplinary Guideline Polypharmacy in the Elderly.


Prof. Dr. Veerle Foulon, Belgium

Prof. Foulon is vice-dean of the Faculty of Pharmaceutical Sciences of the KU Leuven, and former board member of Pharmaceutical Care Network Europe (PCNE). Prof. Foulon teaches communication skills, pharmacotherapy and self-medication, and coordinates different internship programs at the Leuven University. She is also promotor of master theses in Pharmaceutical Care, and is involved in postgraduate training.

The research of Veerle Foulon (°1974; PharmD 1997; PhD 2001) mainly focuses on the role of the pharmacist in the rational use of drugs in the ambulatory setting (pharmaceutical care). This includes studies on the impact of collaborative practice and of (electronic) tools on patient safety and continuity in medication management.


Prof. Dr. Henk Jan Guchelaar, the Netherlands

Henk-Jan Guchelaar studied Pharmacy at the Rijksuniversiteit Groningen (RuG) and specialized as a hospital pharmacist and clinical pharmacologist.  Since 2003, he is employed as a clinical pharmacist and clinical pharmacologist and professor of clinical pharmacy and chair of the department of Clinical Pharmacy & Toxicology at Leiden University Medical Center. 

Since october 2008, he is also appointed professor of Clinical Pharmacy at the Faculty of Science, Leiden Academic Center for Drug Research, University Leiden and chair of the Leiden University focus area ‘Translational Drug Discovery and Development’.

Pharmaceutical patientcare in oncology is his main area of clinical interest. He is program leader of the research program ‘Personalised Therapeutics’  investigating interindividual variability of drug response with an emphasis on pharmacogenomics. He is founder and board member of the Leiden Network for Personalised Therapeutics ( He is (co-)author of more than 575 (Web of Science indexed) articles (Pubmed: 335) in international peer reviewed scientific journals, more than 100 articles in Dutch journals and 20 (chapters in) books.  From 2010-2016 he was a member of the national Central Committee on Research Involving Human Subjects, from 2003, he is vice-chair of the Dutch Society for Clinical Pharmacology and Biopharmacy, and since 2016 he is member of the Dutch Medicines Evaluation Board. Since 2017, he is member of Council for Medical Sciences of the Royal Dutch Academy of Science. Henk-Jan is founder of the new Master of Pharmacy, Leiden University Medical Center, University of Leiden.


Dr. Nejc Horvat, Slovenia

Nejc Horvat graduated in 2007 with theme titled: “Development of a questionnaire measuring patient satisfaction with pharmacy services”. In 2014, he defended his doctoral thesis titled: “Evaluation of pharmacy services from the patient and expert perspective”. Currently, he is a member of the Chair of Social Pharmacy at University of Ljubljana, Faculty of Pharmacy, Slovenia. He is also a board member of the PCNE from 2014 onwards. His research focus is primarily the outcomes research particularly evaluation of pharmacy services, drug related problems and medication literacy.

20170207 Nejc Horvat IFP C75T1233

Prof. Mitja Kos, Slovenia

Mitja Kos is an associate professor for social pharmacy at the Faculty of Pharmacy, University of Ljubljana, Slovenia and the Head of the Chair of Social Pharmacy. From the beginning of his career he has been developing skills in several different areas including pharmacoepidemiology, pharmacoeconomics, outcomes research, clinical pharmacy and informatics. The focus of his scientific and professional activities are comparative effectiveness and cost-effectiveness of medicines, their safety and pharmacists’ cognitive services. Currently, he is a board member of PCNE and an active member of the commission at the Slovene Chamber of Pharmacies developing medication review services. He is a husband and father of three kids.


Mitja Kos

Mr. Babir Malik, MPharm, United Kingdom

Babir Malik is an author, teacher Practitioner, at the University of Bradford, Green Light Campus Northern Pre-registration Lead, Charity Ambassador for Pharmacist Support, and Law & Ethics Lead for the Royal Pharmaceutical Society Pre-registration Conferences. Babir currently practices in Weldricks Pharmacy, Scunthorpe. In June 2016, his pharmacy was awarded the "Chemist and Druggist" Medicines Optimisation Award for their innovative Local Pharmaceutical Service Intervention Service. As a Teacher Practitioner, his role includes being Respiratory Lead for the Clinical Pharmacy Community Diploma. Furthermore, Babir undertook a 10 week secondment as a Clinical Commissioning Group Pharmacist early in 2016 in North Lincolnshire.


Dr Mahendra G Patel, BPharm PhD FRPharmS FNICE FHEA, United Kingdom

Mahendra is a Senior academic fellow and pharmacist with a national and international profile based at University of Huddersfield. He is an elected UK Board Member and most recently Treasurer for the Royal Pharmaceutical Society and the pharmacy profession. He is Honorary Senior Lecturer Medical School University of Sheffield, and Adjunct Professor of Pharmacy Wilkes University Pennsylvania USA. He iS a Fellow of NICE since 2010 and an advisory member of various panels and committees of NICE.

Mahendra’s career spans community practice, health education and health promotion, academia, and research. He received the Royal Pharmaceutical Society’s prestigious Charter Award 2016 for his exceptional services in advancing the profession and promoting the interests of pharmacy.  He is also one of only 15 national NIHR National Pharmacy Research Champions. Mahendra has helped pioneer student engagement in universities nationally through developing the NICE Student Champions Programme (present in medical, dental, nursing and pharmacy schools since 2011). His research interests lie in health and health inequalities within the BAME groups and medicines adherence.

He has a longstanding association with the South Asian Health Foundation (formerly as their CEO), and similar relationship with the British Heart Foundation. Furthermore, Mahendra has reached out internationallys. In Lebanon, he has been appointed International Honorary Ambassador for the Lebanese pharmacy profession.  Recently he has been appointed Visiting Professor in Pharmacy at the Universiti Sains Malaysia (USM) Penang Malaysia.


Dr. Martina Teichert, PhD, The Netherlands

Scientific advisor at the Royal Dutch Pharmacists Association in The Hague and Associate Professor for Pharmacy Practice Research at Leiden University. Martina is the current chairperson of PCNE.

Martina studied pharmacy and economics at the ‘Technische Universität Carolo Wilhelmina’ in Braunschweig, Germany, and epidemiology at the ‘Vrije Universiteit’ in Amsterdam, the Netherlands.  In 2011 she finished her PhD on pharmacogenetic interactions of coumarines at the’ Erasmus Universiteit’ in Rotterdam, the Netherlands. In 2018 she achieved a qualification in developing educational materials, tests and perform lectures and working groups at Leiden University.

After having worked in several community and hospital pharmacies in Germany and the Netherlands, she is since 2002 employed at the Royal Dutch Pharmacists Association. She started to develop epidemiological tools to detect patients in need for additional pharmaceutical care and to report these outcomes to individual pharmacists and for the whole profession as quality indicators. At present she is a scientific advisor and responsible for the research policy of the association.

Since 2016 she is an associate professor for Master students of Pharmacy at Leiden University. She is responsible for the teaching of epidemiology and statistics and to supervise master theses. She supervises five PhD students on measuring the quality of pharmaceutical care, pharmaceutical care in asthma patients, patient selfmanagement, side effects and pharmacoeconomic evaluations of pharmacogenetic interventions.


Ms. Cathelijne van der Wouden, PharmD, the Netherlands 

PhD Candidate for the Ubiquitous Pharmacogenomics Consortium (U-PGx) at Leiden University Medical Center. Cathelijne studied Pharmacy, at Utrecht University in the Netherlands. Since 2016 she is pursuing a PhD in implementation of pharmacogenetics within the Ubiquitous Pharamcogenomics Consortium. U-PGx is funded by a 15 million Euro EU Horizon 2020 grant.As part of her PhD project Cathelijne works as a coordinating researcher for an international multi-center random ized controlled trial (PREPARE, n=8,100), which is part of the Ubiquitous Pharmacogenomics Consortium. PREPARE is an investigator initiated study, recruiting in seven European countries, aiming to assess the collective clinical utility and cost-effectiveness of implementing a panel of pharmacogenomics markers to personalize pharmacotherapy.


Dr. J.W.Foppe van Mil, PhD, FESCP , the Netherlands

Foppe van Mil (16 July 1950) was registered community pharmacist from 1978 till 2000 in a rural area of the Netherlands. Since 2000 he is pharmacy consultant on PPR and Pharmaceutical Care. In January 2000 he concluded his PhD at the working group Social Pharmacy and Pharmacoepidemiology of the University Centre of Pharmacy in Groningen on the concept of Pharmaceutical Care.

In 1985 he founded Pharma Selecta, an independent and critical Dutch drug bulletin. Between 1994 and 2002 he was member of the Committee for continuing professional education of the section Community Pharmacy of FIP. Between 1996 and 1999 he was Chairman of the Pharmaceutical Care Network Europe (PCNE), and currently he is the professional secretary of that association. He also (co-)organises the conferences for PCNE.

Since 2000 he is Editor-in-Chief of the International Journal for Clinical Pharmacy. He currently teaches medication review, community pharmacy practice, and the writing and reviewing of scientific papers and abstracts in several national and international continuing education programs and conferences. Since 2012 he is a fellow of the ESCP and since 2017 he is a honorary member of PCNE.

RRG 3121




Early bird deadline: 15 December 2018 at 24.00h.

Note 1: The Conference fee includes all scientific events, 3 night accommodation, all breakfasts and lunches, and the dinners on Wednesday and Thursday.

PCNE members also have access to the soapbox sessions, and the General Assembly.


Note 2: If you want to arrive early (on the 5th February) you need to indicate/book this separately on the form below because there is a reduced fee for the Tuesday night.


Full conference fee

€ 775.00

Early bird conference fee (till 15th December)

€ 675.00

Conference fee double room, double occupancy per person

€ 715.00

Conference fee early bird, double room, double occupancy per person

€ 615,00

Extra night 5/6 February incl. breakfast per person per night

€ 45.00

Extra night 9/10 February incl. breakfast per person per night

€ 70.00

Non-participating person/partner incl. breakfast per person per night in double room

€ 70.00



The conference is accredited in the Netherlands. The conference is accredited for Dutch hospital or community pharmacists. Make sure to sign the daily list.

Registration form

Postal address*:
Postal code*:
Email address*:

Choose workshop

First choice workshop*:
Second choice workshop*:

Choose Accomodation and event options

Desired room type*:

Default: 3 nights. Extra nights, including breakfast, cost € 70 per extra night, price per person.
Arrival date*:
Departure date*:
Social event Friday (boat-tour Amsterdam incl. Rijsttafel)
Arrival on 5-2-2019, special rate for room + breakfast
Special diet required? (Which/how)
Remarks or questions:

Payment options

Payment time*:
Billing address equal to address
Name for invoice *:
Invoice address*:
Invoice Postal code*:
Invoice City*:
Invoice Country*:
Coupon (optional):
Payment is only possible through the provided link on this site, or in the invoice. All other payments shall be refused. If for some reason you cannot use the payment link, please contact the PCNE secretariat at